Cramer now sees value in drug stock Valeant after its CEO 'delivered' By: CNBC.com News June 06, 2018 at 11:57 AM EDT Jim Cramer mentions a positive note by Barclays analyst Douglas Tsao on Wednesday regarding Valeant Pharmaceuticals. Read More >>